ArticleCancer medicine2022

Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.

Yuanquan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.